argenx SE (ARGX) stock

ARGXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 19, 2026Score 5/30

$960.04−21.29 (-2.17%)

Close on Nov 13, 2026Market cap –P/E 49.1Yield –

argenx total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

argenx has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?